Joseph Piacentile, M.D., J.D., Esq., is the Founder and CEO of Whistleblowers Against Fraud, LLC (“WAF”), Whistleblowers International LLC (“WBI”), and co-founder and CEO of Piacentile, Stefanowski & Malherbe LLP d/b/a Whistleblowers International. Dr. Joe has dedicated more than 28 years of his professional career to seeking justice against those who commit fraud against the U.S. government. Dr. Joe has assisted the U.S. government in recovering more than $8 billion dollars.Dr. Joe, as he is called in the industry, has been in involved in all manner and types of whistleblower cases, including Federal and State False Claims Act cases, SEC Whistleblower cases, Foreign Corrupt Practice Act cases, California Department of Insurance fraud cases, and has consulted on shareholder class actions, mass tort liability claims, amongst many others.
Dr. Joe is a licensed physician, with a degree from Georgetown University Medical School, and a New York licensed attorney with a degree from New York Law School. He is an expert in a broad array of healthcare and pharmaceutical issues. Dr. Joe has developed an extensive arsenal of expertise across many industries, with a particular level of expertise in pharmaceutical and medical device medico-legal issues, such as illegal kickbacks, off-label marketing, misbranding and “white-coat marketing.”
In addition, he has been granted a number of US Patents for inventions in the marketing and dissemination of Pharmaceutical Point-of-Prescription (PoP) intelligent messaging, compliance and virtual communications of off-label information.
The system is designed to disrupt the way pharmaceutical companies message their products. The system allows pharmaceutical companies and other healthcare stakeholders to message physicians and providers based on real-time, patient-specific data. This means that FDA-approved messages can be embedded in the prescription process. This system affords tremendous efficiencies for the pharmaceutical sales process, real-time metrics, feedback, and total transparency for the government regulators, such as the FDA and the Department of Justice.
- New York
- District of Columbia (application pending)
- New York Law School (J.D.)
- Georgetown University Medical School (M.D.)